Oncoinvent ASA (ONCIN) — Strategic Asset Allocation Index
Oncoinvent ASA (ONCIN) has a Strategic Asset Allocation Index of 0.1% as of June 2025. Strategic assets (PP&E of Nkr75.00K plus long-term investments of Nkr-) total Nkr75.00K, measured against net assets of Nkr67.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ONCIN equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Oncoinvent ASA Strategic Asset Allocation Index (2022–2025)
This chart shows how Oncoinvent ASA's Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the index stands at 0.1%, representing strategic assets of Nkr75.00K against net assets of Nkr67.00 Million NOK. For live market cap and overall valuation, see Oncoinvent ASA market capitalisation.
Annual Strategic Asset Allocation Index for Oncoinvent ASA (2022–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Oncoinvent ASA from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Oncoinvent ASA's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (NOK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.6% | Nkr15.58 Million | Nkr15.58 Million | Nkr- | Nkr146.32 Million | ▲ +9.5 pp |
| 2024 | 1.2% | Nkr1.25 Million | Nkr1.25 Million | Nkr- | Nkr108.33 Million | ▲ +0.8 pp |
| 2023 | 0.3% | Nkr431.00K | Nkr431.00K | Nkr- | Nkr127.48 Million | ▲ +0.3 pp |
| 2022 | 0.0% | Nkr43.00K | Nkr43.00K | Nkr- | Nkr88.50 Million | — |